InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Travere Therapeutics, Inc.

TVTX Clue Score50
United States Fiscal year ends December CIK 0001438533 Results filed 2 Nov 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

75
Insider
Date
Role
Action
Shares
Price
Amount
Eric M Dube
15 Oct 2026
Chief Executive Officer
Sold after exercise
78,400
$55.02
$4.31M
Eric M Dube
15 Oct 2026
Chief Executive Officer
Sold after exercise
37,270
$54.20
$2.02M
Eric M Dube
15 Oct 2026
Chief Executive Officer
Sold after exercise
128,065
$52.97
$6.78M
Eric M Dube
17 Sep 2026
Chief Executive Officer
Sold after exercise
6,802
$64.95
$441.80K
Eric M Dube
17 Sep 2026
Chief Executive Officer
Sold after exercise
101,691
$64.59
$6.57M
Peter Heerma
17 Sep 2026
EVP, Chief Commercial Officer
Sold after exercise
8,282
$65.07
$538.92K
William E. Rote
16 Sep 2026
Chief Research Officer
Sold after exercise
47,746
$63.61
$3.04M
William E. Rote
16 Sep 2026
Chief Research Officer
Sold after exercise
65,104
$63.12
$4.11M
Eric M Dube
16 Sep 2026
Chief Executive Officer
Sold after exercise
96,125
$63.64
$6.12M
Eric M Dube
16 Sep 2026
Chief Executive Officer
Sold after exercise
99,716
$63.26
$6.31M
Peter Heerma
16 Sep 2026
EVP, Chief Commercial Officer
Sold after exercise
79,113
$63.65
$5.04M
Peter Heerma
16 Sep 2026
EVP, Chief Commercial Officer
Sold after exercise
93,604
$63.25
$5.92M
William E. Rote
15 Sep 2026
Chief Research Officer
Sold after exercise
270
$65.31
$17.63K
William E. Rote
15 Sep 2026
Chief Research Officer
Sold after exercise
3,000
$63.65
$190.95K
William E. Rote
15 Sep 2026
Chief Research Officer
Sold after exercise
29,021
$62.66
$1.82M
William E. Rote
15 Sep 2026
Chief Research Officer
Sold after exercise
63,907
$61.99
$3.96M
Sandra Calvin
15 Sep 2026
SVP, Chief Accounting Officer
Sold after exercise
300
$63.66
$19.10K
Sandra Calvin
15 Sep 2026
SVP, Chief Accounting Officer
Sold after exercise
800
$62.85
$50.28K
Sandra Calvin
15 Sep 2026
SVP, Chief Accounting Officer
Sold after exercise
4,275
$62.14
$265.63K
Christopher R. Cline
15 Sep 2026
Chief Financial Officer
Sold after exercise
400
$65.31
$26.12K
Christopher R. Cline
15 Sep 2026
Chief Financial Officer
Sold after exercise
1,900
$63.69
$121.00K
Christopher R. Cline
15 Sep 2026
Chief Financial Officer
Sold after exercise
20,735
$62.61
$1.30M
Christopher R. Cline
15 Sep 2026
Chief Financial Officer
Sold after exercise
27,473
$62.00
$1.70M
Eric M Dube
15 Sep 2026
Chief Executive Officer
Sold after exercise
270
$65.31
$17.63K
Eric M Dube
15 Sep 2026
Chief Executive Officer
Sold after exercise
3,102
$63.64
$197.42K
Eric M Dube
15 Sep 2026
Chief Executive Officer
Sold after exercise
28,796
$62.66
$1.80M
Eric M Dube
15 Sep 2026
Chief Executive Officer
Sold after exercise
63,498
$61.99
$3.94M
Elizabeth E Reed
15 Sep 2026
Chief Legal Officer and GC
Sold after exercise
300
$65.31
$19.59K
Elizabeth E Reed
15 Sep 2026
Chief Legal Officer and GC
Sold after exercise
1,400
$63.69
$89.17K
Elizabeth E Reed
15 Sep 2026
Chief Legal Officer and GC
Sold after exercise
13,874
$62.63
$868.96K
Elizabeth E Reed
15 Sep 2026
Chief Legal Officer and GC
Sold after exercise
21,926
$62.03
$1.36M
Jula Inrig
15 Sep 2026
EVP, Head of R&D & CMO
Sold after exercise
400
$65.31
$26.12K
Jula Inrig
15 Sep 2026
EVP, Head of R&D & CMO
Sold after exercise
1,600
$63.69
$101.90K
Jula Inrig
15 Sep 2026
EVP, Head of R&D & CMO
Sold after exercise
17,284
$62.62
$1.08M
Jula Inrig
15 Sep 2026
EVP, Head of R&D & CMO
Sold after exercise
25,390
$62.02
$1.57M
Peter Heerma
15 Sep 2026
EVP, Chief Commercial Officer
Sold after exercise
1,431
$65.31
$93.46K
Peter Heerma
15 Sep 2026
EVP, Chief Commercial Officer
Sold after exercise
1,400
$63.65
$89.11K
Peter Heerma
15 Sep 2026
EVP, Chief Commercial Officer
Sold after exercise
27,421
$62.59
$1.72M
Peter Heerma
15 Sep 2026
EVP, Chief Commercial Officer
Sold after exercise
71,938
$62.05
$4.46M
Jeffrey A Meckler
10 Sep 2026
Director
Sold after exercise
3,100
$68.09
$211.07K
Jeffrey A Meckler
10 Sep 2026
Director
Sold after exercise
14,000
$67.46
$944.49K
Jeffrey A Meckler
10 Sep 2026
Director
Sold after exercise
1,200
$66.15
$79.38K
Jeffrey A Meckler
10 Sep 2026
Director
Sold after exercise
1,700
$65.39
$111.17K
Gary A Lyons
18 Aug 2026
Director
Sold after exercise
900
$63.86
$57.47K
Gary A Lyons
18 Aug 2026
Director
Sold after exercise
4,100
$63.27
$259.39K
Gary A Lyons
17 Aug 2026
Director
Sold after exercise
500
$64.16
$32.08K
Gary A Lyons
17 Aug 2026
Director
Sold after exercise
2,600
$63.50
$165.10K
Gary A Lyons
17 Aug 2026
Director
Sold after exercise
1,900
$62.53
$118.80K
Roy D. Baynes
12 Jun 2026
Director
Sold after exercise
4,500
$50.00
$225.00K
Timothy Coughlin
12 Jun 2026
Director
Sold after exercise
10,000
$50.07
$500.75K
Roy D. Baynes
5 May 2026
Director
Sold after exercise
4,500
$46.65
$209.93K
Jula Inrig
4 May 2026
Chief Medical Officer
Sold after exercise
20,000
$45.00
$900.00K
Elizabeth E Reed
4 May 2026
Chief Legal Officer and GC
Sold after exercise
20,000
$45.00
$900.00K
Jeffrey A Meckler
4 May 2026
Director
Sold after exercise
8,000
$45.00
$360.00K
Roy D. Baynes
1 May 2026
Director
Sold after exercise
9,750
$44.22
$431.15K
Elizabeth E Reed
14 Apr 2026
Chief Legal Officer and GC
Sold after exercise
7,215
$41.93
$302.52K
Elizabeth E Reed
14 Apr 2026
Chief Legal Officer and GC
Sold after exercise
37,500
$41.07
$1.54M
Sandra Calvin
14 Apr 2026
SVP, Chief Accounting Officer
Sold after exercise
21,977
$41.07
$902.60K
Roy D. Baynes
14 Apr 2026
Director
Sold after exercise
6,750
$42.12
$284.31K
Roy D. Baynes
14 Apr 2026
Director
Sold after exercise
26,000
$41.07
$1.07M
Gary A Lyons
14 Apr 2026
Director
Sold after exercise
8,000
$41.07
$328.56K
Roy D. Baynes
6 Apr 2026
Director
Sold after exercise
10,000
$33.00
$330.00K
Elizabeth E Reed
1 Apr 2026
Chief Legal Officer and GC
Sold after exercise
10,000
$30.00
$300.00K
Eric M Dube
1 Apr 2026
Chief Executive Officer
Sold after exercise
25,098
$31.46
$789.58K
Eric M Dube
1 Apr 2026
Chief Executive Officer
Sold after exercise
34,902
$30.55
$1.07M
Elizabeth E Reed
16 Mar 2026
Chief Legal Officer and GC
Sold after exercise
10,000
$28.09
$280.86K
Eric M Dube
20 Feb 2026
Chief Executive Officer
Sold after exercise
60,000
$30.10
$1.81M
Elizabeth E Reed
17 Feb 2026
Chief Legal Officer and GC
Sold after exercise
4,321
$28.26
$122.12K
Elizabeth E Reed
17 Feb 2026
Chief Legal Officer and GC
Sold after exercise
5,679
$27.50
$156.20K
Eric M Dube
27 Jan 2026
Chief Executive Officer
Sold after exercise
51,865
$30.10
$1.56M
Eric M Dube
23 Jan 2026
Chief Executive Officer
Sold after exercise
8,135
$30.01
$244.15K
Elizabeth E Reed
20 Jan 2026
Chief Legal Officer and GC
Sold after exercise
10,000
$27.34
$273.42K
Jula Inrig
24 Dec 2025
Chief Medical Officer
Sold after exercise
15,000
$42.00
$630.00K
William E. Rote
24 Dec 2025
Chief Research Officer
Sold after exercise
60,000
$40.10
$2.41M
Christopher R. Cline
1 Dec 2025
Chief Financial Officer
Sold after exercise
20,000
$35.01
$700.20K
Show all 118 transactions →

What was left out

Form 4 filings counted 69
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 35
Sales straight out of an exercise 75
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 2,184,722
History held since 26 Dec 2012